Filing Flows › Companies › Freshpet › Analysis traps
Freshpet (FRPT): analysis traps
Where its figures could mislead a reader, and what to check before taking them at face value · Data: Q3 2026, to Sep 30, 2026, filed Nov 4, 2026; rules v1.1
Freshpet (FRPT): 1 rule of 10 triggered on the filings to Sep 30, 2026: FCF growth = the business improved. 1 to review; 2 with insufficient data; 3 not applicable. Each is a question to verify, with the normal explanation that would produce the same figures.
Check these first
FCF growth = the business improved Triggered · severity medium · confidence medium
Free cash flow rose $45M, from −$33M to $12M, but capital expenditure fell by $39M: 86% of the increase came from sources that need not repeat. Operating cash flow before working capital rose by $26M.
Innocent reading: An expansion programme finished, so capex fell back to maintenance levels for good.
A precise DCF value = the true value To review · confidence high
The DCF's point value is 30.09 a share (price 66.16); 78% of it is the terminal value, a number about years no one has seen. Moving operating margin by ±3 pts alone takes it from 20.49 to 39.68; across every method the research ran the range is -39 to 104. The value is a range; the decimals are not information.
Innocent reading: A stable, mature business with a narrow range of outcomes, where the point value is a fair summary.
Every rule
A01 FCF growth = the business improved Triggered severity medium · confidence medium
Free cash flow rose $45M, from −$33M to $12M, but capital expenditure fell by $39M: 86% of the increase came from sources that need not repeat. Operating cash flow before working capital rose by $26M.
The figures and how they are read
| Fiscal year before | FY2024 |
| Fiscal year | FY2025 |
| Operating cash flow, year before | $154M |
| Operating cash flow | $161M |
| Capex, year before | $187M |
| Capex | $148M |
| Free cash flow, year before | −$33M |
| Free cash flow | $12M |
| Change in FCF | $45M |
| Change in capex | −$39M |
| Working capital: change in its cash contribution | −$19M |
| Of which: capex cut | $39M |
| Of which: working capital released | 0.00 |
| Share of the increase that need not repeat | +86.1% |
| Operating cash flow before working capital: change | 25579000.00 |
FCF = operating cash flow − cash capex; ΔFCF = ΔOCF − ΔCapEx; the working-capital part is the change in the cash-bridge items (receivables, inventory, payables, accruals), with the sign of the cash flow statement
Source: FY2025 (cash flow statement, fiscal year) · FY2024 (cash flow statement, fiscal year before)
What would explain it innocently
- An expansion programme finished, so capex fell back to maintenance levels for good
- Suppliers agreed longer payment terms in a contract
- Inventory was brought down after a glut and will stay down
What to look for in the filing
- Maintenance capex (what it costs to keep the assets working)
- Supplier payment terms and any supply-chain financing
- Management's capex guidance for next year
What would show the trap does not apply
- Next year's FCF holds or rises with capex back at its earlier level and working capital no longer releasing cash
- The 10-K's capex guidance and the segment capex show the cut is a completed programme, not deferral
- The working-capital release matches a disclosed change in terms or a divestiture, not stretched payables or a collection push
Look again: next filing.
A07 Stock compensation added back = no economic cost Not triggered confidence high
Stock compensation is 1.3% of revenue: small enough that adding it back changes little.
The figures and how they are read
| Fiscal year | FY2025 |
| Stock compensation | $14M |
| Revenue | $1.1B |
| SBC / revenue | +1.3% |
| Buybacks | 0 |
| Buybacks / SBC | 0.0 |
| Diluted shares, year before | 50.3M shares |
| Diluted shares | 56.0M shares |
| Diluted shares: change | +11.5% |
SBC / revenue from the cash flow statement's add-back; the diluted weighted share count year over year; buybacks from the financing section
Source: FY2025 (stock compensation, buybacks and the diluted share count, fiscal year)
B02 Receivables growing = future cash is certain Not triggered confidence medium
Receivables grew 7% against revenue 10% in Q3 2026; DSO 19 against a median of 21: collections are keeping pace with sales.
The figures and how they are read
| Quarter | Q3 2026 |
| Revenue, year over year | +10.0% |
| Receivables, year over year | +6.6% |
| Quarter before | Q2 2026 |
| Revenue y/y, quarter before | +15.4% |
| Receivables y/y, quarter before | +8.3% |
| Days sales outstanding | 19.4 |
| DSO, median of eight quarters | 20.7 |
| Receivables | $69M |
| Revenue | $318M |
receivables and revenue against the same quarter a year earlier; DSO = receivables / quarterly revenue × days, against the median of the eight quarters before
Source: Q3 2026 (receivables and revenue) · Q3 2025 (the same quarter a year earlier)
B08 Adjusted profit = economic profit Insufficient data
no reconciliation table read from the releases yet and fewer than three quarters with both an adjusted and a GAAP EPS
C02 Low net debt = no refinancing risk Insufficient data
no debt figure could be read from the balance sheet (the filing may tag it in other lines)
D03 EPS growth = profit growth Not triggered confidence high
EPS fell 70% and net income fell 71% in Q3 2026; the share count fell 2.0%: EPS growth follows profit growth.
The figures and how they are read
| Quarter | Q3 2026 |
| Quarter before | Q3 2025 |
| EPS, year before | $1.82 |
| EPS | $0.54 |
| Net income, year before | $102M |
| Net income | $30M |
| Diluted shares, year before | 55.9M shares |
| Diluted shares | 54.7M shares |
| EPS growth | -70.2% |
| Net income growth | -70.8% |
| Diluted shares: change | -2.0% |
| eps from profit | -$1.29 |
| eps from share count | $0.01 |
EPS and net income against the same quarter a year earlier; the EPS bridge attributes the change to profit first, then to the share count (the order is fixed and disclosed)
Source: Q3 2026 (net income, diluted shares, EPS) · Q3 2025 (the same quarter a year earlier)
E02 Low P/E at a cyclical peak = undervalued Not applicable
a loss on a trailing or mid-cycle basis: the P/E has no meaning
E07 A precise DCF value = the true value To review confidence high
The DCF's point value is 30.09 a share (price 66.16); 78% of it is the terminal value, a number about years no one has seen. Moving operating margin by ±3 pts alone takes it from 20.49 to 39.68; across every method the research ran the range is -39 to 104. The value is a range; the decimals are not information.
The figures and how they are read
| dcf value | 30.09 |
| price | 66.16 |
| terminal value share | +78.4% |
| swing by input | Operating margin / ±3 pts / 20.49 / 39.68; Revenue growth (each year) / ±5 pts / 25.88 / 35.11; WACC / ±1 pt / 27.06 / 34.04; Capex (share of revenue) / ±1 pt / 29.01 / 31.16 |
| range all methods | -39.44; 104.0 |
the DCF's point value against the share of it that is the terminal value and the value at each input moved by one step (growth ±5 pts, WACC ±1 pt, margin ±3 pts …); the range across every method the research ran
Source: 2026-11-08 (valuation research)
What would explain it innocently
- A stable, mature business with a narrow range of outcomes, where the point value is a fair summary
- The inputs that matter most are themselves well known (a regulated return, a long contract)
What to look for in the filing
- Which input you believe differs from the research's and why
- What the price implies for growth (the reverse DCF on the fair-value page)
What would show the trap does not apply
- The DCF's value is robust to the terminal growth and discount rate (the range's low end is still above the price)
- The company's cash flows over the next three years track the DCF's early years
Look again: next filing.
J06 A bank's low P/E and high profit = safe Not applicable
not a bank
J08 A REIT's low net income = the dividend is unsafe Not applicable
not a REIT
What the statuses mean
Triggered: the filings show the pattern; read the normal explanations and the missing evidence before concluding anything. To review: one quarter or a weak signal; a reader's judgement, not a pattern. Not triggered: the pattern is absent on these figures. Insufficient data: the filings read so far do not hold what the rule needs; this is not a clean bill. Not applicable: the rule is not meant for this kind of company (a bank's working capital, a loss-making quarter's EPS growth). Out of date: the latest filing is more than fifteen months old.
Severity is what the pattern could mean for cash, value or solvency; confidence is how reliable the inputs and the reading are. The two are kept apart.
Record a view
A reader's judgement, grounds, what would change it and the next review; kept in the browser (needs JavaScript).
Every rule and the companies it triggers on → Freshpet: cash flow → Earnings quality score →
Each rule reads the company's own filings by a fixed formula and says what would explain the same figures innocently. A triggered rule is a question to verify, not a finding of manipulation, and not a view on the stock. Missing data is shown as missing, never as clear. Not investment advice.